Alternatives to hephaistos.bio

Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.

Freenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology.

A nonprofit research organization leveraging AI and biotechnology to understand and treat complex diseases.

AI-powered drug discovery company focused on neurological and neuromuscular diseases, leveraging transcriptomics to accelerate therapeutic development.

Advancing next-generation mRNA medicines.

AI-powered antibody discovery platform.

AI platform for engineering molecular glues to create a new class of medicines.

Advancing scalable microbiome-based therapeutics for severe and chronic diseases.

Combines human immune organoid biology with generative AI to reduce immunogenicity risk in antibody development.

AI drug discovery startup that learns directly from patient biology to identify and design novel medicines, focusing on oncology and fibrosis.

Discovering and developing first-in-class antibody therapeutics by identifying protective antibodies from disease-resilient individuals.

AI drug safety startup

Biotechnology company defining membrane protein spatial relationships to create novel therapeutics for cancer and autoimmune diseases.

Empowering pharmaceutical researchers with advanced molecular understanding.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

AI safety and research company building reliable, interpretable, and steerable AI systems.

Biotechnology company developing and commercializing cell therapies for cancer treatment.

Biotechnology company developing transformative gene-based medicines using CRISPR/Cas9 gene editing technology.

Developing novel therapeutics to restore gut lymphatic function.

Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.

Enzyme-based technology to break down alcohol in the stomach.

A clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.

Biopharmaceutical company developing and commercializing CNS disease treatments.

Developing first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.

Clinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.

Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.

Biopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).

Personalizing cancer care through a novel, physics-informed approach to predict tumor response to therapy.

A global leader in clinical pharmacology and bioanalytical sciences.

A biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases.

AI-powered precision testing for patient identification in clinics and clinical trials.

A clinical-stage biopharmaceutical company developing novel therapies for neurological disorders.

A clinical-stage biopharmaceutical company developing novel immunotherapies.

A biotechnology company developing genetic therapies for rare disorders.

Accelerating patient access to evidence-based innovation in mental health.

A clinical-stage biotechnology company developing in vivo gene editing therapies.

A venture capital firm that operates multiple accelerators and invests in startups globally.

Clinical-stage biopharmaceutical company developing novel treatments for exocrine pancreatic insufficiency.

AI-powered knowledge discovery for life sciences.

Developing TCR-mimetic antibody therapies to treat cancer by targeting peptide-loaded major histocompatibility complexes.

Clinical-stage biopharmaceutical company developing next-generation therapies for obesity and cardiometabolic diseases.

Biotechnology company advancing novel therapeutics using its proprietary LEADS drug discovery platform.

A biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension.

The first Integrated Development and Manufacturing Organization (IDMO) for cell therapies.

Develops nanostructured sensor chips for rapid pathogen identification in food.

An end-to-end imaging company providing enterprise-grade imaging and precision endpoints for clinical trials, focusing on lung and heart disease.

Developing highly targeted, small molecule medicines.

Developing oral small molecule medicines for immunological and chronic diseases.

Developing AI-powered diagnostics for neurodegenerative diseases.

Advancing deupirfenidone as a potential new standard of care for Idiopathic Pulmonary Fibrosis (IPF).

Pioneering vision restoration therapies for severe retinal degenerations.

AI-powered antibody discovery platform.

AI-native biotech company designing next-generation CAR T therapies for solid tumors.

A pharmaceutical company focused on developing long-acting injectable medicines.